ARALEZ PHARMACEUTICALS INC. Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities
ARALEZ PHARMACEUTICALS INC. reported Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities of -$24.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2017-03-31 was -$24.00K.
- ARALEZ PHARMACEUTICALS INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2016-06-30 was -$159.00K.
- ARALEZ PHARMACEUTICALS INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for the quarter ending 2016-03-31 was -$4.58M.
- ARALEZ PHARMACEUTICALS INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for fiscal 2017 was -$24.00K.
- ARALEZ PHARMACEUTICALS INC. dilutive securities, effect on basic earnings per share, dilutive convertible securities for fiscal 2016 was -$4.74M.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 3 month | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 6 month | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 9 month | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$24.00K 10-K · filed 2018-03-14 | |||
| 2017-09-30 | -$24.00K 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | -$24.00K 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | -$24.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$4.74M 10-K · filed 2018-03-14 | |||
| 2016-09-30 | -$4.72M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$159.00K 10-Q · filed 2017-08-09 | -$4.74M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$4.58M 10-Q · filed 2017-05-09 |